Prescription Politics

This series explores the pharmaceutical industry’s efforts to influence politicians. The first uses data visualizations to explore donations from 25 drug company and trade association PACs to more than two-thirds of the sitting members of Congress. Forthcoming work will explore the industry’s giving at the state level. For more of STAT’s coverage of the drug industry’s influence in Washington, subscribe to our free newsletter, D.C. Diagnosis, or sign up for STAT Plus.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy